SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-052721
Filing Date
2023-11-13
Accepted
2023-11-13 07:16:07
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20012491_10q.htm   iXBRL 10-Q 2542777
2 EXHIBIT 2.1 ef20012491_ex2-1.htm EX-2.1 857411
3 EXHIBIT 31.1 ef20012491_ex31-1.htm EX-31.1 15177
4 EXHIBIT 31.2 ef20012491_ex31-2.htm EX-31.2 14825
5 EXHIBIT 32.1 ef20012491_ex32-1.htm EX-32.1 6417
6 EXHIBIT 32.2 ef20012491_ex32-2.htm EX-32.2 6222
  Complete submission text file 0001140361-23-052721.txt   10104193

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA roiv-20230930.xsd EX-101.SCH 71612
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE roiv-20230930_cal.xml EX-101.CAL 69520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE roiv-20230930_def.xml EX-101.DEF 351469
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20230930_lab.xml EX-101.LAB 893249
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20230930_pre.xml EX-101.PRE 492392
68 EXTRACTED XBRL INSTANCE DOCUMENT ef20012491_10q_htm.xml XML 1122692
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-40782 | Film No.: 231395072
SIC: 2834 Pharmaceutical Preparations